Blog
RSS FeedPosted by Michael Wonder on 19 Aug 2024
New PBS listing for migalastat (Galafold) for the treatment of Fabry disease
19 August 2024 - On 1 September 2024, migalastat hydrochloride (Galafold) will become available on the PBS for the treatment ...
Posted by Michael Wonder on 19 Aug 2024
Most expensive treatments remain out of reach without health reform
18 August 2024 - Patients are waiting nearly 600 days to access medicines to which the Therapeutic Goods Administration has ...
Posted by Michael Wonder on 12 Aug 2024
Cheaper medicines for rare genetic disorders and cancer
12 August 2024 - Adults with hereditary transthyretin-mediated amyloidosis and with certain cancers, will now have access to cheaper medicines ...
Posted by Michael Wonder on 04 Aug 2024
Groundbreaking therapy for terminal cancers finally publicly funded
2 August 2024 - A groundbreaking pan-tumour pharmaceutical that can act upon multiple different tumour types has been publicly funded ...
Posted by Michael Wonder on 04 Aug 2024
Agenda for the November 2024 PBAC meeting (version 1)
31 July 2024 - The agenda for the November 2024 PBAC meeting is now available. ...
Posted by Michael Wonder on 01 Aug 2024
Life-changing cancer treatment jab added to PBS
31 July 2024 - Australians fighting lung and liver cancer will soon be able to access a life-saving cancer treatment ...
Posted by Michael Wonder on 01 Aug 2024
Schedule of Pharmaceutical Benefits - 1 August 2024
1 August 2024 - The August 2024 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 29 Jul 2024
Life changing medicine for children with cystic fibrosis
29 July 2024 - Australian children with cystic fibrosis now have access to cheaper medicines earlier under the PBS thanks ...
Posted by Michael Wonder on 22 Jul 2024
Why 10,000 Aussies a year being forced to fund their own cancer treatment
21 July 2024 - Australia’s medicine subsidy scheme is so crippled that a staggering 10,000 patients a year are being forced ...
Posted by Michael Wonder on 19 Jul 2024
Public Summary Documents (first time decisions not to recommend and deferrals) - March 2024 PBAC meeting
19 July 2024 - The Public Summary Documents (first time decisions not to recommend and deferrals) from the March 2024 ...
Posted by Michael Wonder on 11 Jul 2024
Australian children with neuroblastoma given free access to 500,000 dollar cancer drug DFMO
10 July 2024 - Australian children and young adults with neuroblastoma, a cancer that affects the nervous system, will be ...
Posted by Michael Wonder on 08 Jul 2024
Post-market review workplan (May 2024)
8 July 2024 - The post-market review workplan was considered by the PBAC at its intracycle meeting in May 2024. ...
Posted by Michael Wonder on 05 Jul 2024
Public Summary Documents – March 2024 PBAC meeting (round 1)
5 July 2024 - The Public Summary Documents (positive recommendations and subsequent decisions not to recommend) from the March 2024 PBAC ...
Posted by Michael Wonder on 02 Jul 2024
New and expanded PBS listings for breast cancer, leukaemia and lupus treatments
2 July 2024 - Australians with early breast cancer, leukaemia, and types of lupus, and insomnia, will now have access to ...
Posted by Michael Wonder on 01 Jul 2024
DoH publishes revised agenda for July 2024 PBAC meeting (1 July 2024)
1 July 2024 - Version 5 of the agenda for the July 2024 PBAC meeting is now available; one major change. ...